C. Sanderson

发表

Distal regulatory elements play an important role in regulation of the human IL‐5 gene

D. Urwin, G. Schwenger, D. Groth, 2004, European journal of immunology.

GATA-3 Has Dual Regulatory Functions in Human Interleukin-5 Transcription*

V. Mordvinov, G. Schwenger, C. Sanderson, 2001, The Journal of Biological Chemistry.

Binding of Octamer Factors to a Novel 3′-Positive Regulatory Element in the Mouse Interleukin-5 Gene*

V. Mordvinov, C. Sanderson, M. Salerno, 2000, The Journal of Biological Chemistry.

Nuclear factor of activated T cells and YY1 combine to repress IL-5 expression in a human T-cell line.

V. Mordvinov, L. M. Hall, G. Schwenger, 1999, The Journal of allergy and clinical immunology.

Two pathways can activate the interleukin-5 gene and induce binding to the conserved lymphokine element 0.

C. Sanderson, S. Karlen, M. D’Ercole, 1996, Blood.

Binding of octamer factors to the murine IL-5 CLE0 in primary T-cells and a T-cell line.

V. Mordvinov, G. Schwenger, C. Sanderson, 2001, Cytokine.

The mechanism of T cell mediated cytotoxicity III. Changes in target cell susceptibility during the cell cycle

C. Sanderson, J. Thomas, Jennifer Thomas, 1976, Proceedings of the Royal Society of London. Series B. Biological Sciences.

Recombinant human interleukin 5 is a selective eosinophil chemoattractant

Ji Ming Wang, A. Biondi, A. Mantovani, 1989, European journal of immunology.

How is expression of the interleukin‐5 gene regulated?

V. Mordvinov, C. Sanderson, S. Karlen, 1996, Immunology and cell biology.

A fluorometric assay for determining cell growth in lymphocyte proliferation and lymphokine assays.

E. Dotsika, C. Sanderson, 1987, Journal of immunological methods.

Interleukin‐5 binds to heparin/heparan sulfate. A model for an interaction with extracellular matrix

R. Lipscombe, D. R. Coombe, C. Sanderson, 1998, Journal of leukocyte biology.

Eosinophil differentiation of human umbilical cord mononuclear cells and prolonged survival of mature eosinophils by murine EL-4 thymoma cell conditioned medium.

H. Kita, G. Gleich, J. Butterfield, 1991, Cytokine.

Effect of steroids on immunoglobulin-induced eosinophil degranulation.

H. Kita, G. Gleich, C. Sanderson, 1991, The Journal of allergy and clinical immunology.

Eosinophilia in transgenic mice expressing interleukin 5

M. Strath, A. Mellor, C. Sanderson, 1990, The Journal of experimental medicine.

Anti-interleukin 5 strategies as a potential treatment for asthma.

C. Sanderson, A. Singh, A. D. Singh, 1997, Thorax.

IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CD11/18)-dependent manner.

A. Wardlaw, A. Kay, K. Kurihara, 1990, Immunology.

Regulatory effect of cytokines on eosinophil degranulation.

H. Kita, G. Gleich, T. Fujisawa, 1990, Journal of immunology.

Mutation analysis of interleukin‐5 in an asthmatic cohort

J. Goldblatt, P. L. Le Souëf, P. Rye, 1998, Human mutation.

Release of granule proteins from eosinophils cultured with IL-5.

H. Kita, G. Gleich, D. Weiler, 1992, Journal of immunology.

Interleukin-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CD11/18)-dependent manner.

A. Wardlaw, A. Kay, A. Hartnell, 1991, International archives of allergy and applied immunology.

The conserved lymphokine element 0 is a powerful activator and target for corticosteroid inhibition in human interleukin-5 transcription

V. Mordvinov, E. Arthaningtyas, C. Sanderson, 2005, Growth factors.

Biological and molecular characteristics of interleukin-5 and its receptor.

V. Mordvinov, W. Lutz, M. de Boer, 1998, International reviews of immunology.

Interleukin-5, eosinophils, and disease.

C. Sanderson, C. Sanderson, 1992, Blood.

Pharmacological implications of interleukin-5 in the control of eosinophilia.

C. Sanderson, 1992, Advances in pharmacology.

Recombinant human interleukin 5 is an eosinophil differentiation factor but has no activity in standard human B cell growth factor assays

R. Callard, A. Boyd, J. Gordon, 1987, European journal of immunology.

The RgpA-Kgp Proteinase-Adhesin Complexes of Porphyromonas gingivalis Inactivate the Th2 Cytokines Interleukin-4 and Interleukin-5

Yu-Yen Chen, E. Reynolds, N. O’Brien-Simpson, 2009, Infection and Immunity.

A human T-cell line with inducible production of interleukins 5 and 4. A model for studies of gene expression.

V. Mordvinov, U. Kees, M. de Boer, 1999, Journal of immunological methods.

Interleukin 5 binds to heparin/heparan sulphate: A model for an interaction with the extracellular matrix

R. Lipscombe, D. R. Coombe, C. Sanderson, 1997 .

Interleukin-5 and Eosinophilia

C. Sanderson, 1993 .

Mutated interleukin-5 monomers are biologically inactive.

B. Ely, A. McKenzie, C. Sanderson, 1991, Molecular immunology.

The biological role of interleukin 5.

C. Sanderson, Colin J. Sanderson, 1990, International journal of cell cloning.

Production and functional properties of eosinophils from bone marrow cultures.

M. Strath, C. Sanderson, 1985, Journal of cell science.

Mouse immunoglobulin isotypes mediating cytotoxicity of target cells by eosinophils and neutrophils.

M. Strath, C. Sanderson, A. Lopez, 1983, Immunology.

IgG and complement receptors on purified mouse eosinophils and neutrophils.

M. Strath, C. Sanderson, A. Lopez, 1981, Immunology.

Interleukin-5: a drug target for allergic diseases.

D. Urwin, C. Sanderson, 2000, Current opinion in investigational drugs.

Regulation of IL-5 expression.

V. Mordvinov, C. Sanderson, 2001, Archivum immunologiae et therapiae experimentalis.

Identification of two novel palindromic regulatory elements in the murine interleukin-5 promoter.

V. Mordvinov, G. Schwenger, C. Sanderson, 1998, Molecular immunology.

Control of eosinophilia.

C. Sanderson, 1991, International archives of allergy and applied immunology.

Eosinophil differentiation factor (interleukin-5).

C. Sanderson, 1990, Immunology series.

Identification of regions within the third FnIII-like domain of the IL-5Ralpha involved in IL-5 interaction.

P. Czabotar, C. Sanderson, J. Holland, 2000, Cytokine.

Eosinophilic interleukin 5 (IL‐5) transgenic mice: eosinophil activity and impaired clearance of Schistosoma mansoni

K. Piper, P. Hagan, D. Harkin, 1997, Parasite immunology.

Eosinophils. A Comprehensive Review and Guide to the Scientific and Medical Literature

C. Sanderson, 1989 .

Soluble interleukin 2 receptors are released from the cell surface of normal murine B lymphocytes stimulated with interleukin 5.

G. Nossal, M. Loughnan, C. Sanderson, 1988, Proceedings of the National Academy of Sciences of the United States of America.

The mechanism of T cell mediated cytotoxicity V. Morphological studies by electron microscopy

A. Glauert, C. Sanderson, 1977, Proceedings of the Royal Society of London. Series B. Biological Sciences.

Interleukin-5: From Molecule to Drug Target for Asthma

C. Sanderson, 1998 .

Analysis of interleukin 5 receptors on murine eosinophils: a comparison with receptors on B13 cells.

S. Barry, M. Strath, A. McKenzie, 1991, Cytokine.

Transcription Factor GATA-3 Is Involved in Repression of Promoter Activity of the Human Interleukin-4 Gene

V. Mordvinov, G. Schwenger, C. Sanderson, 2005, Biochemistry (Moscow).

Infection of IL5 transgenic mice with Mesocestoides corti induces very high levels of IL5 but depressed production of eosinophils.

M. Strath, C. Sanderson, L. Dent, 1992, Experimental hematology.

The mechanism of T cell mediated cytotoxicity I. The release of different cell components

C. Sanderson, 1976, Proceedings of the Royal Society of London. Series B. Biological Sciences.

Differentiation antigens on mouse eosinophils and neutrophils identified by monoclonal antibodies

M. Strath, C. Sanderson, Angel Lopez, 1984, British journal of haematology.

Dexamethasone Suppresses Human Interleukin-5 Gene Promoter

V. Mordvinov, E. Arthaningtyas, G. Schwenger, 2005, Bulletin of Experimental Biology and Medicine.

Eosinophils and not lymphoid K cells kill Trypanosoma cruzi epimastigotes

Angel F. Lopez, C. Sanderson, M. M. Moreno, 1977, Nature.

Biochemical and morphological characterization of the killing of human monocytes by a leukotoxin derived from Actinobacillus actinomycetemcomitans

R. Dean, N. Taichman, C. Sanderson, 1980, Infection and immunity.

The lysis of Trypanosoma cruzi epimastigotes by eosinophils and neutrophils.

C. Sanderson, A. Lopez, M. M. Moreno, 1978, International journal for parasitology.

The mechanism of K cell (antibody-dependent) cell mediated cytotoxicity I. The release of different cell components

C. Sanderson, J. Thomas, Jennifer Thomas, 1977, Proceedings of the Royal Society of London. Series B. Biological Sciences.

Different effector cell types in antibody-dependent cell-mediated cytotoxicity

I. Clark, C. Sanderson, G. A. Taylor, 1975, Nature.

THE MECHANISM OF LYMPHOCYTE‐MEDIATED CYTOTOXICITY

C. Sanderson, 1981, Biological reviews of the Cambridge Philosophical Society.

Interleukin-5: an eosinophil growth and activation factor.

C. Sanderson, 1988, Developments in biological standardization.

The mechanism of T-cell mediated cytotoxicity. VI. T-cell projections and their role in target cell killing.

A. Glauert, C. Sanderson, 1979, Immunology.

The mechanism of K cell (antibody-dependent) cell mediated cytotoxicity II. Characteristics of the effector cell and morphological changes in the target cell

C. Sanderson, J. Thomas, Jennifer Thomas, 1977, Proceedings of the Royal Society of London. Series B. Biological Sciences.

Identification of residues involved in binding of IL5 to βcom using βIL3 and βcom chimeras

P. Czabotar, C. Sanderson, J. Holland, 1999 .

Interleukin 5 and its Receptor

C. Sanderson, 1998 .

Antibody-dependent, cell-mediated cytotoxicity of nucleated mammalian cells by rat eosinophils and neutrophils.

C. Sanderson, A. Lopez, 1982, International archives of allergy and applied immunology.

A comparison of the cytotoxic activity of eosinophils and other cells by 51 chromium release and time lapse microcinematography.

C. Sanderson, J. Thomas, 1978, Immunology.

The uptake and retention of chromium by cells.

C. Sanderson, 1976, Transplantation.

Applications of 51 Chromium in cell biology and medicine

C. Sanderson, 1982 .

An evaluation of an assay for DNA synthesis in lymphocytes with [3H]thymidine and harvesting on to glass fibre filter discs.

C. Sanderson, T. Ahern, G. A. Taylor, 1976, Journal of immunological methods.

The mechanism of T cell mediated cytotoxicity IV. Studies on communicating junctions between cells in contact

C. Sanderson, Jennifer Thomas, P. Hall, 1977, Proceedings of the Royal Society of London. Series B. Biological Sciences.

Binding of YY1 and Oct1 to a novel element that downregulates expression of IL-5 in human T cells.

V. Mordvinov, M. de Boer, G. Schwenger, 1999, The Journal of allergy and clinical immunology.

CHAPTER 11 – Interleukin-5

R. Osmond, D. Urwin, G. Schwenger, 2003 .

The detection of antibody and demonstration of immunoglobulin class, with inert particles and indicator red cells.

C. Sanderson, 1971, Immunology.

Human interleukin‐5 induces staphylococcal A Cowan 1 strain‐activated human B cells to secrete IgM

E. Benson, C. Sanderson, J. Bertolini, 1993, European journal of immunology.

Interleukin-5, Eosinophils, and Disease

C. Sanderson, 1992 .

Role of nuclear factor of activated T cells (NFAT) in the expression of interleukin-5 and other cytokines involved in the regulation of hemopoetic cells.

V. Mordvinov, M. de Boer, C. Sanderson, 1999, The international journal of biochemistry & cell biology.

The mechanism of T cell mediated cytotoxicity II. morphological studies of cell death by time-lapse microcinematography

C. Sanderson, 1976, Proceedings of the Royal Society of London. Series B. Biological Sciences.

The mechanism of K-cell (antibody-dependent) mediated cytotoxicity. III. The ultrastructure of K cell projections and their possible role in target cell killing.

A. Glauert, C. Sanderson, 1979, Journal of cell science.

Detection of eosinophil differentiation factor and its relationship to eosinophilia in Mesocestoides corti-infected mice.

M. Strath, C. Sanderson, 1986, Experimental hematology.

Molecular and Cellular Biology of Eosinophil Differentiation Factor (Interleukin‐5) and its Effects on Human and Mouse B Cells

C. Sanderson, H. Campbell, I. Young, 1988, Immunological reviews.

The T-cell mediated immune response to Schistosoma mansoni. I. Generation of stage-specific, MHC-restricted proliferative T-cell clones to soluble egg antigens.

N. Mak, C. Sanderson, 1985, Immunology.

Antibody dependent cell-mediated cytotoxicity of Trypanosoma cruzi: the release of tritium-labelled RNA, DNA and protein

C. Sanderson, A. Lopez, M. M. Moreno, 1978, Parasitology.

New directions in understanding interleukin-5 gene expression.

G. Schwenger, C. Sanderson, 1998, Leukemia & lymphoma.

Specific Activation of Human Interleukin-5 Depends on de Novo Synthesis of an AP-1 Complex*

Marc A. Thomas, V. Mordvinov, E. Arthaningtyas, 2002, The Journal of Biological Chemistry.

The activity of the human interleukin-5 conserved lymphokine element 0 is regulated by octamer factors in human cells.

V. Mordvinov, C. Sanderson, M. A. Thomas, 1999, European journal of biochemistry.

THE KINETICS OF 51,Cr RELEASE FROM TARGET CELLS IN CELL MEDIATED CYTOTOXICITY AND THE RELATIONSHIP TO THE KINETICS OF KILLING

C. Sanderson, Geoffrey A. Taylor, 1975, Cell and tissue kinetics.

Antibody-dependent cell-mediated cytotoxicity in the rat. The role of macrophages.

C. Sanderson, G. A. Taylor, 1976, Immunology.

The mechanism of T-cell mediated cytotoxicity. VIII. Zeiosis corresponds to irreversible phase (programming for lysis) in steps leading to lysis.

C. Sanderson, 1981, Immunology.

Morphological aspects of lymphocyte mediated cytotoxicity.

C. Sanderson, 1982, Advances in experimental medicine and biology.

A morphological study of the interaction between Trypanosoma cruzi and rat eosinophils, neutrophils and macrophages in vitro.

W. de Souza, C. Sanderson, 1979, Journal of cell science.

Antibody‐dependent cytotoxicity of Trypanosoma cruzi antigen‐coated mouse cell lines by eosinophils and neutrophils

R. R. Santos, C. Sanderson, A. Lopez, 1983, Parasite immunology.

The growth of Trypanosoma cruzi in human diploid cells for the production of trypomastigotes

C. Sanderson, J. Thomas, C. Twomey, 1980, Parasitology.

Lectins and lipopolysaccharides as linking agents for the red cell linked antigen test.

C. Sanderson, 1970, Immunology.

Expressed luciferase viability assay (ELVA) for the measurement of cell growth and viability.

D. R. Coombe, C. Sanderson, S. Stevenson, 1998, Journal of immunological methods.

Interleukin-3 production as a sensitive measure of T-lymphocyte activation in the mouse.

E. Dotsika, C. Sanderson, 1987, Immunology.

The Mechanisms of Cell-Mediated Cytotoxicity

C. Sanderson, 1981 .

Recombinant human interleukin 5 is a selective activator of human eosinophil function

J. Gamble, M. Vadas, I. G. Young, 1988, The Journal of experimental medicine.

Molecular cloning, nucleotide sequence, and expression of the gene encoding human eosinophil differentiation factor (interleukin 5).

I. G. Young, C. Sanderson, C. Sanderson, 1987, Proceedings of the National Academy of Sciences of the United States of America.

Constitutive synthesis of interleukin-3 by leukaemia cell line WEHI-3B is due to retroviral insertion near the gene

I. G. Young, C. Sanderson, C. Sanderson, 1985, Nature.

Production and purification of recombinant human interleukin-5 from yeast and baculovirus expression systems.

E. Ingley, I. G. Young, C. Sanderson, 1991, European journal of biochemistry.

Analysis of the 5' and 3'UTRs in the post-transcriptional regulation of the interleukin-5 gene.

C. Sanderson, M. D’Ercole, S. Karlen, 1999, Biochimica et biophysica acta.

Interleukin terminology in disarry

G. Klaus, C. Sanderson, 1986, Nature.

EOSINOPHIL DIFFERENTIATION FACTOR IgE

M. Strath, D. Warren, C. Sanderson, 2003 .